Metraipolis › archive › dc_a787b472cfbe

Efficacy and safety of PD-1/PD-L1 inhibitors versus chemotherapy or cetuximab in the treatment of platinum-refractory recurrent or metastatic head and neck… — Europe PMC PMID:42602046

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42602046
DOI
10.3389/fphar.2026.1675407
License (as archived)
solo-consultazione
Archived
2026-10-17T06:51:31.244Z
SHA-256 of the archived text
c9185a529d2b7607005b64b4060a3b7e827f9f16ed302b81a2257d1f2ae31adc
Stable URL of this page
https://metraipolis.com/documento/dc_a787b472cfbe

How to cite

Efficacy and safety of PD-1/PD-L1 inhibitors versus chemotherapy or cetuximab in the treatment of platinum-refractory recurrent or metastatic head and neck… — Europe PMC PMID:42602046 — Europe PMC (en), https://europepmc.org/article/MED/42602046 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a787b472cfbe (Metraipolis archive dc_a787b472cfbe, sha256 c9185a529d2b7607005b64b4060a3b7e827f9f16ed302b81a2257d1f2ae31adc)
BibTeX
@misc{dca787b472cfbe,
  title = {Efficacy and safety of PD-1/PD-L1 inhibitors versus chemotherapy or cetuximab in the treatment of platinum-refractory recurrent or metastatic head and neck… — Europe PMC PMID:42602046},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42602046},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a787b472cfbe; sha256 c9185a529d2b7607005b64b4060a3b7e827f9f16ed302b81a2257d1f2ae31adc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42602046. Agents can read the archived copy with the MCP tool read_document.